According to PTC Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 75,377,997. At the end of 2023 the company had 75,377,997 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 75.37 M | 3.75% |
2022 | 72.65 M | 2.81% |
2021 | 70.66 M | 4.48% |
2020 | 67.64 M | 19.57% |
2019 | 56.57 M | 12.39% |
2018 | 50.33 M | 21.74% |
2017 | 41.34 M | 21% |
2016 | 34.16 M | 0.75% |
2015 | 33.91 M | 5.08% |
2014 | 32.27 M | 35.59% |
2013 | 23.8 M | 67.77% |
2012 | 14.18 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Novartis NVS | 2,044,000,000 | 2,611.67% | ๐จ๐ญ Switzerland |
Vertex Pharmaceuticals VRTX | 258,000,000 | 242.27% | ๐บ๐ธ USA |
Xencor XNCR | 60,621,534 | -19.58% | ๐บ๐ธ USA |
Sarepta Therapeutics
SRPT | 88,889,000 | 17.92% | ๐บ๐ธ USA |
Fate Therapeutics
FATE | 98,568,012 | 30.76% | ๐บ๐ธ USA |
Avidity Biosciences RNA | 74,097,000 | -1.70% | ๐บ๐ธ USA |